The approval is for Winlevi (clascoterone cream 1 per cent), which is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older, the company said in a statement.
from Moneycontrol Business News https://ift.tt/5j4ldMm
from Moneycontrol Business News https://ift.tt/5j4ldMm